NCT00932555View on ClinicalTrials.gov

EffeKt Taiwan- Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Taiwan

CompletedOBSERVATIONAL
Enrollment

82

Participants

Timeline

Start Date

April 30, 2009

Study Completion Date

December 31, 2011

Conditions
Hemophilia A
Interventions
BIOLOGICAL

Recombinant Factor VIII (Kogenate FS, BAY14-2222)

Patients under daily life treatment receiving Kogenate according to local drug information.

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT00932555 - EffeKt Taiwan- Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Taiwan | Biotech Hunter | Biotech Hunter